Immatics N.V. (IMTX)
NASDAQ: IMTX · Real-Time Price · USD
10.00
+0.14 (1.42%)
Mar 9, 2026, 4:00 PM EDT - Market closed

Revenue by Segment

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Biotechnology
155.84M54.00M172.83M34.76M31.25M
Biotechnology Growth
188.60%-68.76%397.17%11.23%69.40%
Total
155.84M54.00M172.83M34.76M31.25M
Total Growth
188.60%-68.76%397.17%11.23%69.40%

Revenue by Geography

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Germany
155.84M54.00M172.83M34.76M31.25M
Germany Growth
188.60%-68.76%397.17%11.23%69.40%
Total
155.84M54.00M172.83M34.76M31.25M
Total Growth
188.60%-68.76%397.17%11.23%69.40%
Source: S&P Global Market Intelligence.